Within its last year performance, IMUX fell by -0.71%, with highs and lows ranging from $2.11 to $0.95, whereas the simple moving average jumped by 4.86% in the last 200 days.
On September 09, 2024, Leerink Partners started tracking Immunic Inc (NASDAQ: IMUX) recommending Outperform. A report published by B. Riley Securities on August 27, 2024, Initiated its previous ‘Buy’ rating for IMUX. SVB Leerink also Downgraded IMUX shares as ‘Mkt Perform’, setting a target price of $5 on the company’s shares in a report dated October 21, 2022. H.C. Wainwright Initiated an Buy rating on September 19, 2022, and assigned a price target of $26. Aegis Capital initiated its ‘Buy’ rating for IMUX, as published in its report on April 15, 2021. JMP Securities’s report from March 24, 2021 suggests a price prediction of $55 for IMUX shares, giving the stock a ‘Mkt Outperform’ rating. SVB Leerink also rated the stock as ‘Outperform’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Immunic Inc (IMUX)
Immunic Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -143.47% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.75, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and IMUX is registering an average volume of 389.27K. On a monthly basis, the volatility of the stock is set at 8.89%, whereas on a weekly basis, it is put at 8.03%, with a loss of -13.04% over the past seven days. Furthermore, long-term investors anticipate a median target price of $12.75, showing growth from the present price of $1.40, which can serve as yet another indication of whether IMUX is worth investing in or should be passed over.
How Do You Analyze Immunic Inc Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.92%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 60.01% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
IMUX shares are owned by institutional investors to the tune of 60.01% at present.
